WEBINAR: How can generic manufacturers break into new markets with RH products?29th June 2017
Many generic manufacturers of reproductive health supplies struggle to break into new markets. They initiate and successfully complete WHO prequalification or other quality assurance processes, and invest significant amounts of...
Transfer saves 3,000 IUDs from possible expiry and non-use15th June 2017
Three thousand intra-uterine devices (IUDs) have been saved from possible expiry and non-use—yielding more than $2,000 in cost savings and in human terms, averting an estimated 1,993 unwanted pregnancies. This transfer was made...
New Pregnancy Test Resource Offers Procurers Guidance on Quality21st May 2017
A new resource offers procurement groups guidance on quality standards and performance specifications for pregnancy tests. The document, “Quality and Performance Guidance on Selection of Pregnancy Tests for Procurement,” was...
Chinese youth project triples the projected number of hospital partners1st March 2017
An Innovation Fund-supported project in China set out to partner with two hospitals to train their doctors in providing young people with Long Acting Reversible Contraceptives (LARCs). But project leader MSI China, supported by a team of experts, surpassed the original plan and signed agreements with six pilot hospitals instead.
New study explores the realities of registering misoprostol and mifepristone in Latin America27th February 2017
Professional health association support and prior registration for obstetric use were found to be critical factors in securing national regulatory approval of misoprostol and mifepristone for medical abortion, a new study has found.